MedPath

The efficacy of oral nutritional therapy with ENORAS for the patients after gastrectomy and the evaluation for the nutritional index: exploratory prospective study

Phase 2
Recruiting
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000047451
Lead Sponsor
Kobe University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with allergies to oral nutritional supplements (2) Patients who are judged unsuitable for the study by the principal investigator or sub-investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body weight loss rate at 3 months after gastrectomy
Secondary Outcome Measures
NameTimeMethod
The adherence of ENORAS oral intake dose (continuous internal use completion rate), Total calorie intake at the 3 months after surgery (estimate from images or records of meal after gastrectomy), ECOG-PS, Nutritional index from blood test (TP, ALB, TLC), Bioelectrical impedance analysis, Visceral fat area and Skeletal muscle index from CT images
© Copyright 2025. All Rights Reserved by MedPath